MASS: Muscle and disease in postmenopausal women

MASS:绝经后妇女的肌肉和疾病

基本信息

项目摘要

ABSTRACT Sarcopenia (low muscle mass) and diabetes are two highly prevalent and disabling chronic health conditions affecting older women. There is emerging evidence that diabetes and impaired insulin-glucose homeostasis may accelerate age-related loss of muscle mass. It is critically important to examine modifiable risk factors (e.g., muscle mass, dysglycemia) that contribute to risk of functional impairment, falls and fractures (the 3Fs) in older adults. Our study will address a key knowledge gap: the extent to which insulin-glucose homeostasis is associated with loss of muscle mass over time in aging women and whether this varies by race/ethnicity. Moreover, this study will examine the feedback loop between impaired insulin-glucose homeostasis and loss of skeletal muscle mass. Until recently, the ability to fully characterize change in muscle mass in large studies of community dwelling older adults has been limited by challenges associated with obtaining measures of muscle mass. This is a critical barrier to progress. This project will use a novel at-home remote sample collection protocol (D3Cr method) and finger-prick blood collection kit to examine longitudinal change in muscle mass and insulin-glucose homeostasis in 3177 postmenopausal women from the Women’s Health Initiative (WHI). The WHI is a large, ongoing prospective cohort study of postmenopausal women with 30 years of follow-up. Study participants will be drawn from a WHI sub-cohort, the Long Life Study 2 (LLS2), a diverse cohort of older women (56% from racial/ethnic minority groups; mean age 85 years). The study aims are to: 1) provide insight into longitudinal patterns of change in D3Cr-muscle mass in postmenopausal women as they age, and their risk for functional decline increases, by race/ethnicity, diabetes status, and according to level of glycemic control, 2) examine the cyclical relationship between impaired insulin-glucose homeostasis and change in D3Cr-muscle mass using advanced statistical approaches, and 3) use machine learning methods to develop multivariate risk stratification algorithms, including D3Cr-muscle mass, indices of impaired insulin-glucose homeostasis, and objective measures of functional capacity (grip strength, gait speed), to identify postmenopausal women at highest risk of the 3 Fs. This project addresses an urgent need identified by the NIA for research on geroscience, including research that determines the rate of aging processes and mechanisms underlying age-related change. In the future, these results will be used to develop interventions designed to mitigate harmful effects of sarcopenia and diabetes and promote healthy aging in postmenopausal women, including women from racial/ethnic minority groups that are typically underrepresented in health research.
抽象的 肌肉减少症(肌肉质量低)和糖尿病是两种非常普遍且致残的慢性健康状况 越来越多的证据表明,糖尿病会影响老年女性。 年龄可能会加速与肌肉质量相关的损失,检查可改变的风险因素至关重要。 (例如,肌肉质量、血糖异常)会导致功能障碍、跌倒和骨折(3F)的风险 我们的研究将解决一个关键的知识差距:胰岛素-葡萄糖稳态的程度。 与老年女性随着时间的推移肌肉质量损失有关,以及这是否因种族/民族而异。 此外,这项研究将检查胰岛素-葡萄糖稳态受损和胰岛素抵抗丧失之间的反馈回路。 直到最近,大型研究才能够充分描述肌肉质量的变化。 社区居住的老年人受到与获取肌肉测量相关的挑战的限制 这是阻碍该项目取得进展的一个关键障碍。 方案(D3Cr 方法)和指尖采血套件,用于检查肌肉质量的纵向变化 女性健康倡议 (WHI) 的 3177 名绝经后妇女的胰岛素-血糖稳态。 WHI 是一项针对绝经后女性的大型、持续的前瞻性队列研究,并进行了 30 年的随访。 研究参与者将从 WHI 子队列中抽取,即长寿研究 2 (LLS2),这是一个多元化的老年人队列 女性(56% 来自少数种族/族裔群体;平均年龄 85 岁)。该研究旨在:1) 提供见解。 研究绝经后妇女 D3Cr 肌肉质量随年龄变化的纵向模式,以及她们的 根据种族/民族、糖尿病状况以及血糖水平,功能下降的风险会增加 控制,2)检查受损的胰岛素-葡萄糖稳态和变化之间的周期性关系 D3Cr-肌肉质量使用先进的统计方法,以及3)使用机器学习方法来开发 多变量风险分层算法,包括 D3Cr-肌肉质量、胰岛素-葡萄糖受损指数 稳态和功能能力的客观测量(握力、步态速度),以确定 处于 3 F 风险最高的绝经后妇女 该项目解决了 3 F 所确定的迫切需求。 NIA 负责老年科学研究,包括确定衰老过程速率和 未来,这些结果将用于制定干预措施。 旨在减轻肌肉减少症和糖尿病的有害影响,促进绝经后健康老龄化 妇女,包括在卫生领域代表性不足的少数种族/族裔群体的妇女 研究。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Hailey Rose Banack其他文献

Hailey Rose Banack的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Hailey Rose Banack', 18)}}的其他基金

Ms. LILAC: Muscle Mass in the Life and Longevity After Cancer (LILAC) Study
LILAC 女士:癌症后生命和长寿 (LILAC) 研究中的肌肉质量
  • 批准号:
    10446331
  • 财政年份:
    2022
  • 资助金额:
    $ 69.5万
  • 项目类别:
Ms. LILAC: Muscle Mass in the Life and Longevity After Cancer (LILAC) Study
LILAC 女士:癌症后生命和长寿 (LILAC) 研究中的肌肉质量
  • 批准号:
    10589078
  • 财政年份:
    2022
  • 资助金额:
    $ 69.5万
  • 项目类别:

相似国自然基金

老年期痴呆患者基础性日常生活活动能力损害的认知神经心理学基础及测量优化
  • 批准号:
  • 批准年份:
    2021
  • 资助金额:
    55 万元
  • 项目类别:
    面上项目
基于VR技术的养老机构老年人ADL康复训练和评估量化体系构建及应用研究
  • 批准号:
    81902295
  • 批准年份:
    2019
  • 资助金额:
    20.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

A First-in-class Topical Immunoregulatory Therapeutic for Psoriasis
一流的牛皮癣局部免疫调节疗法
  • 批准号:
    10820331
  • 财政年份:
    2023
  • 资助金额:
    $ 69.5万
  • 项目类别:
Autonomic Dysfunction in Patients with HFpEF
HFpEF 患者的自主神经功能障碍
  • 批准号:
    10587484
  • 财政年份:
    2023
  • 资助金额:
    $ 69.5万
  • 项目类别:
Perspectives of Correctional Officers about Older Adults in Prison: A Grounded Theory Study
惩教人员对监狱中老年人的看法:扎根理论研究
  • 批准号:
    10749275
  • 财政年份:
    2023
  • 资助金额:
    $ 69.5万
  • 项目类别:
Improving exercise rehabilitation efficacy and outcomes in Veterans with peripheral artery disease: Targeting oxidative stress and inflammation
提高患有外周动脉疾病的退伍军人的运动康复效果和结果:针对氧化应激和炎症
  • 批准号:
    10638943
  • 财政年份:
    2023
  • 资助金额:
    $ 69.5万
  • 项目类别:
Molecular origins and evolution to chemoresistance in germ cell tumors
生殖细胞肿瘤中化学耐药性的分子起源和进化
  • 批准号:
    10443070
  • 财政年份:
    2023
  • 资助金额:
    $ 69.5万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了